Trials / Conditions / Relapsed Diffuse Large B-cell Lymphoma (DLBCL)
Relapsed Diffuse Large B-cell Lymphoma (DLBCL)
3 registered clinical trials studyying Relapsed Diffuse Large B-cell Lymphoma (DLBCL) — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Italian Real-World Study of Epcoritamab in Relapsed or Refractory DLBCL NCT07393204 | Andrés José Maria Ferreri | — |
| Recruiting | A Phase I Trial to Establish the Safety and Maximum Tolerated Dose of High-affinity Autologous BCMA-targeting NCT05836896 | Technische Universität Dresden | Phase 1 |
| Active Not Recruiting | Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous NCT02570542 | Memorial Sloan Kettering Cancer Center | Phase 2 |